Clalit Health Services announces a $ 3,419,910 grant received from The Leona M. and Harry B. Helmsley Charitable Trust to clinically evaluate the efficacy of real-time AI decision support technology. Clalit Health Services will conduct the research at its Schneider Children’s Medical Center’s Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, a national referral center for childhood diabetes in Israel. The research will evaluate people with type 1 or type 2 diabetes undergoing multiple daily injections. The program will include a series of clinical studies aimed at validating a new technology provided by DreaMed Diabetes with the goal to empower people with diabetes to achieve better self-management of their condition and provide personalized real-time insulin dosing recommendations. The protocol aims to improve glycemic control and enhance diabetes treatment satisfaction for people affected with the condition.
Read more here.
The post [DreaMed in Odessa American] The Helmsley Charitable Trust Awards Clalit Health Services $ 3.4M to Evaluate Closed-loop AI Technology at Schneider Children’s Medical Center for People Requiring Insulin Injection Therapy appeared first on OurCrowd Blog.
OEN re-imagines its annual awards for a pandemic year, honors 12 companies Portland Business Journal
“startups when:1d” – Google News